Crossref
FINANCIAL TOXICITY OF ADVANCED PANCREATIC CANCER: A REAL-WORLD COST ANALYSIS
HPB · 2026 · 28 · S142
DOI: 10.1016/j.hpb.2026.04.239 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von F. Ladak und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ladak, F., Mavros, M., Chan, K., Nguyen, L., Mozessohn, L., Coburn, N., & Raphael, M. (2026). FINANCIAL TOXICITY OF ADVANCED PANCREATIC CANCER: A REAL-WORLD COST ANALYSIS. HPB, 28, S142. https://doi.org/10.1016/j.hpb.2026.04.239
Vancouver
Ladak F, Mavros M, Chan K, Nguyen L, Mozessohn L, Coburn N, et al. FINANCIAL TOXICITY OF ADVANCED PANCREATIC CANCER: A REAL-WORLD COST ANALYSIS. HPB. 2026;28:S142. doi:10.1016/j.hpb.2026.04.239
BibTeX
@article{Ladak2026,
author = {Ladak, F. and Mavros, M. and Chan, K. and Nguyen, L. and Mozessohn, L. and Coburn, N. and Raphael, M.},
title = {FINANCIAL TOXICITY OF ADVANCED PANCREATIC CANCER: A REAL-WORLD COST ANALYSIS},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S142},
doi = {10.1016/j.hpb.2026.04.239}
}
EUVIMED